Jerry S. Lanchbury, Chief Scientific Officer at MYRIAD GENETICS INC (MYGN), sold 146,590 shares at $33.55 ($4.9M) on 2021-07-12, disclosed to the SEC on 2021-07-14.
Open-market sale of $4.9M MYGN by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.55 | 13,295 | $446K | 9.1% |
| 2 | $33.55 | 13,295 | $446K | 9.1% |
| 3 | $33.55 | 36,705 | $1.2M | 25.0% |
| 4 | $33.55 | 36,705 | $1.2M | 25.0% |
| 5 | $33.69 | 3,295 | $111K | 2.3% |
| 6 | $33.69 | 3,295 |
| $111K |
| 2.3% |
| 7 | $33.74 | 40,000 | $1.3M | 27.4% |
| Total | $33.61 avg | 146,590 | $4.9M | 100% |
| Filing → |
| MYGN | SELL | 2021-08-06 | $2.0M | — | Filing → |
| MYGN | SELL | 2021-08-05 | $4.5M | — | Filing → |
| MYGN | SELL | 2021-07-12 | $3.3M | — | Filing → |